| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates
|
Cole, Susan
|
|
|
35 |
1 |
p. 2-11
|
artikel
|
| 2 |
Cisplatin, rather than oxaliplatin, increases paracellular permeability of LLC-PK1 cells via activating protein kinase C
|
Zhang, Yunpeng
|
|
|
35 |
1 |
p. 111-116
|
artikel
|
| 3 |
Computational prediction of cytochrome P450 inhibition and induction
|
Kato, Harutoshi
|
|
|
35 |
1 |
p. 30-44
|
artikel
|
| 4 |
CYP2D6 genotyping analysis and functional characterization of novel allelic variants in a Ni-Vanuatu and Kenyan population by assessing dextromethorphan O-demethylation activity
|
Gutiérrez Rico, Evelyn Marie
|
|
|
35 |
1 |
p. 89-101
|
artikel
|
| 5 |
Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics
|
Omori, Kotaro
|
|
|
35 |
1 |
p. 117-123
|
artikel
|
| 6 |
Development of a new Japanese guideline on drug interaction for drug development and appropriate provision of information
|
Ishiguro, Akihiro
|
|
|
35 |
1 |
p. 12-17
|
artikel
|
| 7 |
Evaluation of drug–drug interactions in drug metabolism: Differences and harmonization in guidance/guidelines
|
Iwatsubo, Takafumi
|
|
|
35 |
1 |
p. 71-75
|
artikel
|
| 8 |
Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles
|
Goto, Eri
|
|
|
35 |
1 |
p. 151-159
|
artikel
|
| 9 |
Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions
|
Kimoto, Emi
|
|
|
35 |
1 |
p. 18-29
|
artikel
|
| 10 |
Identification of non-P450 enzymes involved in the metabolism of new drugs: Their significance in drug interaction evaluation and prodrug disposition
|
Nishiya, Yumi
|
|
|
35 |
1 |
p. 45-55
|
artikel
|
| 11 |
Influence of gastrointestinal activity on the absorption of nilotinib
|
Sasaki, Maaya
|
|
|
35 |
1 |
p. 102-110
|
artikel
|
| 12 |
Numerical analysis of apparent decitabine uptake in HCT116 cells: Incorporation of a bidirectional first-order kinetic parameter for ENT1 transport and Michaelis-Menten parameters for subsequent phosphorylation
|
Ueda, Kumiko
|
|
|
35 |
1 |
p. 124-130
|
artikel
|
| 13 |
Pharmacokinetic modeling and simulation for dose rationale of doripenem in neonates and infants
|
Matsuo, Yumiko
|
|
|
35 |
1 |
p. 145-150
|
artikel
|
| 14 |
Prediction of regioselectivity and preferred order of CYP1A1-mediated metabolism: Solving the interaction of human and rat CYP1A1 forms with ligands on the template system
|
Yamazoe, Yasushi
|
|
|
35 |
1 |
p. 165-185
|
artikel
|
| 15 |
Preface
|
Takada, Tappei
|
|
|
35 |
1 |
p. 1
|
artikel
|
| 16 |
Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters
|
Nozaki, Yoshitane
|
|
|
35 |
1 |
p. 56-70
|
artikel
|
| 17 |
Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug–drug interactions
|
Maeda, Kazuya
|
|
|
35 |
1 |
p. 76-88
|
artikel
|
| 18 |
Relationships between plasma lactate, plasma alanine, genetic variations in lactate transporters and type 2 diabetes in the Japanese population
|
Higuchi, Issei
|
|
|
35 |
1 |
p. 131-138
|
artikel
|
| 19 |
rs622342A>C in SLC22A1 is associated with metformin pharmacokinetics and glycemic response
|
Naja, Khaled
|
|
|
35 |
1 |
p. 160-164
|
artikel
|
| 20 |
The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients
|
Sukkha, Sayamon
|
|
|
35 |
1 |
p. 139-144
|
artikel
|
Tijdschrift beschrijving